Advertisement

E-Cigarettes: Matching Risks With Regulations

Published:October 08, 2020DOI:https://doi.org/10.1016/j.amepre.2020.07.011
      In 2019, e-cigarettes captured public attention as never before, with more than 2,600 cases of e-cigarette or vaping product use–associated lung injury (EVALI) and at least 57 U.S. deaths by early 2020.
      • King BA
      • Jones CM
      • Baldwin GT
      • Briss PA
      The EVALI and youth vaping epidemics: implications for public health.
      Local and state governments responded with bans on flavored e-cigarette sales. The U.S. Food and Drug Administration (FDA) later announced restrictions on sales of flavored e-cigarette cartridges. Yet these responses conflated the epidemic of youth e-cigarette use—largely attributed to flavors—with the EVALI outbreak driven primarily by the use of informal or illicit vaping products that contained vitamin E acetate and, often, tetrahydrocannabinol, marijuana's principal psychoactive chemical.
      • King BA
      • Jones CM
      • Baldwin GT
      • Briss PA
      The EVALI and youth vaping epidemics: implications for public health.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • King BA
        • Jones CM
        • Baldwin GT
        • Briss PA
        The EVALI and youth vaping epidemics: implications for public health.
        N Engl J Med. 2020; 382: 689-691
        • Nguyen T
        There's a community of DIY vapers who mix their own flavors - and more are joining.
        Vox. September 27, 2019;
        • National Academies of Sciences, Engineering, and Medicine
        Public Health Consequences of E-Cigarettes.
        The National Academies Press, Washington, DC2018
        • MacDonald A
        • Middlekauff HR
        Electronic cigarettes and cardiovascular health: what do we know so far?.
        Vasc Health Risk Manag. 2019; 15: 159-174
        • Glasser AM
        • Collins L
        • Pearson JL
        • et al.
        Overview of electronic nicotine delivery systems: a systematic review.
        Am J Prev Med. 2017; 52: e33-e66
        • Goniewicz ML
        • Smith DM
        • Edwards KC
        • et al.
        Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes.
        JAMA Netw Open. 2018; 1e185937
        • Hajek P
        • Phillips-Waller A
        • Przulj D
        • et al.
        A randomized trial of e-cigarettes versus nicotine-replacement therapy.
        N Engl J Med. 2019; 380: 629-637
        • Soneji S
        • Barrington-Trimis JL
        • Wills TA
        • et al.
        Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis [published correction appears in JAMA Pediatr. 2018;172(1):92–93] [published correction appears in JAMA Pediatr. 2018;172(1):98].
        JAMA Pediatr. 2017; 171: 788-797
        • Levy DT
        • Warner KE
        • Cummings KM
        • et al.
        Examining the relationship of vaping to smoking initiation among U.S. youth and young adults: a reality check.
        Tob Control. 2019; 28: 629-635
        • Friedman AS
        • Wu RJ
        Do local Tobacco-21 laws reduce smoking among 18 to 20 year-olds?.
        Nicotine Tob Res. 2020; 22: 1195-1201
        • Friedman AS
        • Buckell J
        • Sindelar JL
        Tobacco-21 laws and young adult smoking: quasi-experimental evidence.
        Addiction. 2019; 114: 1816-1823
        • Chaloupka FJ
        • Sweanor D
        • Warner KE
        Differential taxes for differential risks—toward reduced harm from nicotine-yielding products.
        N Engl J Med. 2015; 373: 594-597
        • Apelberg BJ
        • Feirman SP
        • Salazar E
        • et al.
        Potential public health effects of reducing nicotine levels in cigarettes in the United States.
        N Engl J Med. 2018; 378: 1725-1733
      1. Discover more about JUUL pods & flavors. JUUL. https://www.juul.com/resources/What-is-JUUL-Vape-Juice-All-JUUL-Pod-Flavors. Updated July 2, 2019. Accessed December 13, 2019.

        • Benowitz NL
        • Henningfield JE
        Reducing the nicotine content to make cigarettes less addictive.
        Tob Control. 2013; 22: i14-i17
        • Pepper JK
        • Ribisl KM
        • Brewer NT
        Adolescents’ interest in trying flavoured e-cigarettes.
        Tob Control. 2016; 25: ii62-ii66
        • Tam J
        • Warner KE
        Students’ cigarette smoking and the perceived nicotine content of their e-cigarettes.
        Am J Prev Med. 2018; 55: 376-383
        • Bonhomme MG
        • Holder-Hayes E
        • Ambrose BK
        • et al.
        Flavoured non-cigarette tobacco product use among U.S. adults: 2013-2014.
        Tob Control. 2016; 25: ii4-ii13
        • Friedman AS
        • Xu S.
        Associations of flavored e-cigarette uptake with subsequent smoking initiation and cessation.
        JAMA Netw Open. 2020; 3e203826
        • Buckell J
        • Marti J
        • Sindelar JL
        Should flavours be banned in cigarettes and e-cigarettes? Evidence on adult smokers and recent quitters from a discrete choice experiment.
        Tob Control. 2019; 28: 168-175